198904-31-3
  • Air Pro198904-31-3

198904-31-3

We have more than 10 years of experience in custom synthesis of compounds. If you are looking for a supplier or manufacturer of Atazanavir (CAS No.: 198904-31-3) please contact us. We can provide customers with custom synthesis from grams to kilograms and the production of tons of compounds. Now, we also hope to meet your needs for Atazanavir (CAS No.: 198904-31-3) and other compounds. We can provide high-quality compounds and good service fou you.

Send Inquiry

Product Description

Name

Atazanavir

Synonyms

methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate;Zrivada;Atazanavir;2aqu;Reyataz;UNII-QZU4H47A3S;[3H]-Atazanavir

Molecular Formula

C38H52N6O7

Molecular Weight

704.85500

CAS Number

198904-31-3

purity

97%

Storage conditions

Sealed in dry,Store in freezer, under -20°C











Application:Atazanavir (CAS No.: 198904-31-3), sold under the trade name Reyataz, is an antiretroviral drug of the protease inhibitor (PI) class. Like other antiretrovirals, it is used to treat infection of human immunodeficiency virus (HIV).
Atazanavir is distinguished from other PIs in that it can be given once-daily (rather than requiring multiple doses per day) and has lesser effects on the patient's lipid profile (the amounts of cholesterol and other fatty substances in the blood). Like other protease inhibitors, it is used only in combination with other HIV medications.
The U.S. Food and Drug Administration (FDA) approved atazanavir on June 20, 2003. Atazanavir is the first PI approved for once-daily dosing, and also appears to be less likely to cause lipodystrophy and elevated cholesterol as side effects. It may also not be cross-resistant with other PIs. When boosted with ritonavir it is equivalent in potency to lopinavir for use in salvage therapy in patients with a degree of drug resistance, although boosting with ritonavir reduces the metabolic advantages of atazanavir.
It is on the World Health Organization's List of Essential Medicines, the most important medications needed in a basic health system.



Hot Tags: 198904-31-3,

Related Category

Send Inquiry

Please feel free to give your inquiry in the form below. We will reply you within 24 hours.